Vipin Chandra: Proud and Emotional Moment at ASPIRE 2026
Vipin Chandra, Director at Matcare Maternity, shared a post on LinkedIn:
”A deeply proud and emotional moment for me at ASPIRE 2026, Beijing — witnessing our team present 14 scientific studies on one of the world’s most respected platforms in reproductive medicine.
From clinical research and meta-analyses to real-world IVF data, embryology, implantation science, male infertility, and advanced ART analytics — the diversity and quality of work presented truly reflected the passion, curiosity, and scientific spirit of our team.
What made me happiest was seeing the appreciation and engagement from international faculties, experts, and delegates toward the practical and research-driven work emerging from India.
As someone leading this incredible group, I feel proud not just of the studies — but of the culture of learning, questioning, collaboration, and evidence-based medicine our team is building together.
Heartfelt congratulations to:
Dr Amol Naik , Dr Anjali Sharma, Dr Amrita Singh, Dr Ammar Karia, Dr Tanya Singh, Simmi Arora , Dr Sarah Zaidi, Dr Pratibha Singh, Dr Shyam N Gupta , Dr. Nikita Singh , Dr Akansha Jangid and everyone involved in this journey.
This is only the beginning.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 8, 2026, 10:40Hrishikesh Pai: Role of Vaginal and Gut Microbiota in HPV Progression and Cervical Cancer
-
Jun 8, 2026, 10:35Peter Humaidan: Meeting with the Colleagues at London Women’s Clinic
-
Jun 8, 2026, 10:28Mitra Bakhtiari: How AI Supports Research in The Diagnosis of Intrauterine Growth Restriction
-
Jun 8, 2026, 00:39Why The Medication in Your IVF Cycle is Chosen So Carefully – Fertility Plus
-
Jun 8, 2026, 00:37Happy Pride From Your Friends, Allies, and Community Members at ASRM – ASRM
-
Jun 8, 2026, 00:35Birth Outcomes After IVF Among Cancer Survivors – Fertility and Sterility
-
Jun 7, 2026, 15:54Barb Collura: 3 Key Takeaways From My May Travels
-
Jun 7, 2026, 15:53Christopher Robinson: New Trial Compares Mirtazapine and Ondansetron for Treatment of Hyperemesis Gravidarum
-
Jun 7, 2026, 15:44MFM Specialists and Genetic Counselors Collaborating to Support High-Risk Pregnancy Care – National Society of Genetic Counselors